Of the three patients (two male, one female, 42–86 years), the female patient (GII), as well as one male patient (GV), suffered a primary form of GBM with an IDH1 wildtype, whereas patient two (GIV) owned a secondary GBM and showed a mutation of the IDH1 gene (Table 1). This evidence concerns the gene IDH1 and glioblastoma.